ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01212380
Recruitment Status : Completed
First Posted : September 30, 2010
Last Update Posted : May 9, 2016
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
Jennifer Woyach, Ohio State University Comprehensive Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2014
  Actual Study Completion Date : September 2015